Inamrinone

Inamrinone (formerly Amrinone) is a phosphodiesterase III inhibitor with positive inotropic and vasodilatory properties used in the short-term management of decompensated heart failure. Mediocon Inc supplies IP/BP/EP/USP compliant Inamrinone API for injectable formulations.

Key Features

• PDE-III inhibitor with inotropic activity
• IP/BP/EP/USP compliant quality
• Suitable for parenteral formulations
• For acute heart failure management

Applications

• Short-term management of decompensated heart failure
• Inotropic support in ICU settings
• Perioperative cardiac support
• Acute hemodynamic stabilization

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings